Maternal and neonatal colonisation of group B streptococcus at Muhimbili National Hospital in Dar es Salaam, Tanzania: prevalence, risk factors and antimicrobial resistance

Joachim, Agricola; Matee, Mecky I.; Massawe, Furaha A.; Lyamuya, Eligius F.
January 2009
BMC Public Health;2009, Vol. 9 Issue 1, p437
Academic Journal
Background: Group B streptococcus (GBS), which asymptomatically colonises the vaginal and rectal areas of women, is the leading cause of septicemia, meningitis and pneumonia in neonates. In Tanzania no studies have been done on GBS colonisation of pregnant women and neonates. This study was conducted in Dar es Salaam, Tanzania to determine the prevalence of GBS colonisation among pregnant women, the neonatal colonisation rate and the antimicrobial susceptibility, thus providing essential information to formulate a policy for treatment and prevention regarding perinatal GBS diseases. Methods: This cross sectional study involved 300 pregnant women attending antenatal clinic and their newborns delivered at Muhimbili National Hospital (MNH) between October 2008 and March 2009. High vaginal, rectal, nasal, ear and umbilical swabs were cultured on Todd Hewitt Broth and in 5% sheep blood agar followed by identification of isolates using conventional methods and testing for their susceptibility to antimicrobial agents using the Kirby-Bauer method. Results: GBS colonisation was confirmed in 23% of pregnant women and 8.9% of neonates. A higher proportion of GBS were isolated from the vagina (12.3%) as compared to the rectum (5%). Prolonged duration of labour (>12 hrs) was significantly shown to influence GBS colonisation in neonates P < 0.05. Other risk factors such as prolonged rupture of membrane, intrapartum fever, low birth weight and HIV infection did not correlate with GBS colonisation. All isolates were sensitive to vancomycin and ampicillin. Resistance to clindamycin, erythromycin and penicillin G was found to 17.6%, 13% and 9.4%, respectively. Conclusion: Our findings seem to suggest that a quarter of pregnant women attending ANC clinic at MNH and approximately 10% of their newborns are colonised with GBS. All isolates were found to be sensitive to vancomycin and ampicillin which seem to be the most effective antibiotics for the time being. However there is a need for continuous antibiotics surveillance of GBS to monitor trend of resistance. The high isolation frequency of GBS among pregnant women suggests routine antenatal screening at 35 to 37 weeks of gestation in order to provide antibiotic prophylaxis to GBS carrier.


Related Articles

  • Quimioprofilaxis para evitar la colonizaci�n materna por estreptococo grupo B. Consecuencias de no adoptar la recomendaci�n internacional. Reyna-Figueroa, Jes�s; Ortiz-Ibarra, Federico Javier; P�rez-Antonio, Beatriz; Navarro-God�nez, Sujey; Casanova-Rom�n, Gerardo; Garc�a-Carrillo, Laura Erika // Salud P�blica de M�xico;mar/abr2008, Vol. 50 Issue 2, p155 

    Objective. To know the criteria which determine the chemoprophylaxis on pregnant women colonized by Streptococcus agalactiae (GBS) and the impact in our environment. Material and Methods. A retrospective analysis, identifying pregnant women with isolation of Streptococcus agalactiae on screening...

  • Genetic islands of Streptococcus agalactiae strains NEM316 and 2603VR and their presence in other Group B Streptococcal strains. Herbert, Mark A.; Beveridge, Catriona J.E.; McCormick, David; Aten, Emmelien; Jones, Nicola; Snyder, Lori A.S.; Saunders, Nigel J. // BMC Microbiology;2005, Vol. 5, p1 

    Background: Streptococcus agalactiae (Group B Streptococcus; GBS) is a major contributor to obstetric and neonatal bacterial sepsis. Serotype III strains cause the majority of late-onset sepsis and meningitis in babies, and thus appear to have an enhanced invasive capacity compared with the...

  • Survival and biofilm formation by Group B streptococci in simulated vaginal fluid at different pHs. Borges, Sandra; Silva, Joana; Teixeira, Paula // Antonie van Leeuwenhoek;Mar2012, Vol. 101 Issue 3, p677 

    The Group B Streptococcus (GBS, Streptococcus agalactiae) is an important cause of neonatal and maternal infection. GBS is a commensal organism of the lower gastrointestinal and vaginal tract. A frequent mode of neonatal infection is vertical transmission from pregnant women to their foetus or...

  • Sepsis neonatal tardía por estreptococo del grupo B. Transmisión a través de lactancia materna. Collado, Marta Bernardino; Movilla, Roberto Ortiz; Fernández, Blanca Álvarez; Vilaplana, Lucía Cabanillas; Hierro, Paloma García; Amador, José Tomás Ramos // Revista de Enfermedades Infecciosas en Pediatria;jul-sep2011, Vol. 25 Issue 97, p17 

    Group B Streptococcus, or Streptococcus agalactiae is a major causative agent of bacterial infection in newborns, with two clinical forms of onset: early and late. Of the latter, several transmission mechanisms are known: horizontal, nosocomial or community acquired. There are few cases reported...

  • Evaluation of chromID strepto B as a screening media for Streptococcus agalactiae. Toyohisa Morita; Dongyun Feng; Yoko Kamio; Isao Kanno; Teruo Somaya; Kazuhito Imai; Misaki Inoue; Mutsunori Fujiwara; Akihito Miyauchi // BMC Infectious Diseases;2014, Vol. 14 Issue 1, p1 

    Background Streptococcus agalactiae (Group B Streptococcus, GBS), a leading cause of sepsis and meningitis in infants, can be transmitted vertically from mother to infant during passage through the birth canal. Detection of GBS colonization in perinatal women is a major strategy for the...

  • Prevention of Early-onset Neonatal Group B Streptococcal Disease. Soto Marió, M. J.; Valenzuela, I.; Vásquez, A. E.; Illanes, S. E. // Reviews in Obstetrics & Gynecology;2013, Vol. 6 Issue 2, p63 

    Streptococcus agalactiae, also known as Group B Streptococcus (GBS), is an opportunistic pathogen that colonizes the gastrointestinal and genitourinary tracts of up to 50% of healthy adults and newborns; it is responsible for significant morbidity and mortality. Early detection can be used to...

  • Prevention of perinatal group B streptococcal infections: A review with an Indian perspective. Narava, S.; Rajaram, G.; Ramadevi, A.; Prakash, G. V.; Mackenzie, S. // Indian Journal of Medical Microbiology;Jan2014, Vol. 32 Issue 1, p6 

    Group B Streptococcus (GBS) is an important cause of maternal and neonatal morbidity and mortality in many parts of the world. Asymptomatic colonisation of the vagina and rectum with Group B streptococci is common in pregnancy. Maternal colonisation of GBS can vary depending on ethnicity and...

  • GROUP B STREPTOCOCCUS NEONATAL MENINGITIS-LESS COMMON CAUSE OF NEONATAL MENINGITIS IN PAKISTAN AND DISPARITY BETWEEN CSF CULTURE AND OTHER PARAMETERS. Hussain, Shabbir; Ahmad, Tariq Mahmood; Tarar, Saba Haider // Pakistan Armed Forces Medical Journal;8/31/2015, Vol. 65 Issue 4, p577 

    Neonatal bacterial meningitis is a devastating illness with significant mortality and morbidity. Incidence and etiology of neonatal bacterial sepsis and meningitis varies among developed and developing countries. We are reporting a case of 6 days old neonate who presented with fever, refusal to...

  • Comparison of pre- and intrapartum screening of group B streptococci and adherence to screening guidelines: a cohort study. Kunze, Mirjam; Zumstein, Katharina; Markfeld-Erol, Filiz; Elling, Roland; Lander, Fabian; Prömpeler, Heinrich; Berner, Reinhard; Hufnagel, Markus // European Journal of Pediatrics;Jun2015, Vol. 174 Issue 6, p827 

    Implementation of guidelines for group B streptococcal (GBS) prepartum screening (PS) rarely has been prospectively evaluated. To assess PS at 35-37 weeks of gestation and compare its predictive value to that of an intrapartum screening (IS) within 7 days of delivery, a surveillance cohort study...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics